NR2F6 and neoplasm: Adoptive transfer of CD3Nr2f6 siRNA polyclonal T cells that demonstrated significant Nr2f6 silencing (Fig. 5a) was sufficient for a significant delay in tumor growth when compared to mice receiving CD3control siRNA cells (Fig. 5b−d).